Skip to Main Content

Advertisement

Skip Nav Destination

OnlineFirst

Research Article June 9 2025
Defining non-small cell lung cancer tumor microenvironment changes at primary and acquired immune checkpoint inhibitor resistance using clinical and real-world data
Cancer Research Communications (2025)
Research Article June 6 2025
Histone deacetylase inhibitors target DNA replication regulators and replication stress in Ewing sarcoma cells
Cancer Research Communications (2025)
Research Article June 6 2025
Protein-level analysis of differential response to chemotherapy in triple negative breast cancer identifies CYP1B1 as a biomarker for chemotherapy resistance.
Cancer Research Communications (2025)
Research Article June 6 2025
Genetic ancestry, Intrinsic Tumor Subtypes, and Breast Cancer Survival in Latin American Women
Cancer Research Communications (2025)
Research Article June 4 2025
Real-World Data on Risk Factors for Emergency Department Visits to Treat Outpatient Chemotherapy Associated Toxicities
Cancer Research Communications (2025)
Research Article June 4 2025
Cisplatin-induced APE2 overexpression disrupts MYH9 function and causes hearing loss
Cancer Research Communications (2025)
Research Article June 3 2025
High-throughput drug screening of clear cell ovarian cancer organoids reveal vulnerability to proteasome inhibitors and dinaciclib and identify AGR2 as a therapeutic target
Cancer Research Communications (2025)
Research Article May 30 2025
A phase 1 safety study of evexomostat (SDX-7320) in late-stage cancer patients: an anti-angiogenic, insulin-sensitizing drug conjugate targeting MetAP2
Cancer Research Communications (2025)

or Create an Account

Close Modal
Close Modal